Item 8.01. Other Events.
On January 27, 2023, Jasper Therapeutics, Inc. (the "Company") issued a press
release announcing the closing of its previously announced underwritten public
offering of shares of its voting common stock, $0.0001 par value per share
("Common Stock"). In the offering, the Company sold an aggregate of 69,000,000
shares of Common Stock at a public offering price of $1.50 per share, which
includes the exercise in full by the underwriters of their option to purchase
9,000,000 additional shares of Common Stock. A copy of the press release is
attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated
herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Number Description
99.1 Press Release, dated January 27, 2023.
104 Cover Page Interactive Data File, formatted in Inline Extensible
Business Reporting Language (iXBRL).
1
© Edgar Online, source Glimpses